Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03428828 · ClinicalTrials.gov registry record · NA
Neurofeedback for Treatment Resistant Depression
A NA study, sponsored by Kymberly Young.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03428828 is a NA study that has completed, run by Kymberly Young. The registered enrollment target is 60 participants.
The verdict
NCT03428828, a NA study, has completed, sponsored by Kymberly Young.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical efficacy of real-time functional magnetic resonance imaging neurofeedback (rtfMRI-nf) training to increase the amygdala's response to positive autobiographical memories in patients with depression who are considered treatment-resistant
Interventions
- DEVICE Amygdala Neurofeedback
- DEVICE Parietal Neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03428828
The ClinicalTrials.gov registry entry for NCT03428828 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kymberly Young, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amygdala Neurofeedback is the first listed.
NCT03428828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03428828 about?
NCT03428828 is a clinical study titled "Neurofeedback for Treatment Resistant Depression". The purpose of this study is to determine the clinical efficacy of real-time functional magnetic resonance imaging neurofeedback (rtfMRI-nf) training to increase the amygdala's response to positive autobiographical memories in patients with depression who are considered treatment-resistant
What is the current status of trial NCT03428828?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-10-22. Estimated completion is 2026-03-01.
What interventions are being tested in trial NCT03428828?
The interventions under investigation include: Amygdala Neurofeedback (DEVICE), Parietal Neurofeedback (DEVICE).
Who is sponsoring clinical trial NCT03428828?
This trial is sponsored by Kymberly Young, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.